The Rotterdam Eye Hospital — Clinical Trial Site

11 Registered trials

5 Currently recruiting

Organisation

The Rotterdam Eye Hospital

Location

Rotterdam, Netherlands

Identifier

ORG-100030682

Address

Schiedamse Vest 180, 3011 BH, Netherlands

Departments

502: Ophthalmology
5280005: Ophthalmology
medische retina
NA
OPHTHALMOLOGY
Rotterdams Oogheelkundig Instituut

Clinical trials at this site (11)

Search interface

A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with… Not authorised

2024-515199-10-00 Retinitis Pigmentosa 4
An Open-label, Multicenter Trial to Assess Safety and Efficacy of a Subretinal Administration of AAVB-039 Pending

2025-522207-15-01 Stargardt Disease (STGD1) 7
An efficacy and safety study of cenegermin ophthalmic solution compared with vehicle in the treatment of PCED Pending

2025-523443-35-00 Persistent Corneal Epithelial Defect (PCED) 5
LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose) in the Treatment of … Recruiting

2024-513356-15-00 Acquired Blepharoptosis 5 2024-12-30
Vitrectomy and subretinal TPA for submacular haemorrhage secondary to wet AMD (TIGER). Recruiting

2023-504751-28-00 Exudative age-related macular degeneration 5 2024-09-24
A Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retiniti… Recruiting

2024-515199-10-01 Retinitis Pigmentosa 4 2025-09-29
Long-term Extension Study for Participants with Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 … Recruiting

2022-500747-21-00 Geographic Atrophy 4 2025-02-27
Pred Forte® versus placebo eye drops in chronic central serous chorioretinopathy trial (PICS trial) Recruiting

2024-511575-15-00 Central serous chorioretinopathy 5 2025-01-29
A study to evaluate Intravitreal JNJ-81201887(AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary… Ended

2022-500746-16-00 Geographic Atrophy 4 2023-08-11
A Study to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of RO7200220 Administered Intravitreally in Patients wit… Ended

2022-501793-19-00 Uveitic Macular Edema 5 2023-04-21
A clinical study of OPT-302 with aflibercept compared to aflibercept alone in patients with neovascular age-related macular degeneration Ended

2024-512880-30-00 Neovascular Age-related Macular Degeneration (wet AMD) 5 2021-08-27